Metrics as of 10/16/2026, 08:36 AM (Berlin time), refresh in progress.
Formycon Stock
Formycon AG
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Germany
- CEO
- Stefan Glombitza
- Employees
- 196
- Market cap
- €352 M
- IPO
- 04/01/2011
Headquartered in Planegg, Germany, Formycon AG operates within the healthcare sector and specializes in the development and commercialization of biosimilars. The company's robust product pipeline includes the segment FYB201, a biosimilar equivalent to Lucentis intended for the treatment of neovascular age-related…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Formycon stock: price history
1D
+2.7%
1W
+4.5%
1M
+0.4%
6M
+0.5%
YTD
-22.2%
1Y
-17.3%
2Y
-62.1%
5Y
-61.8%
10Y
+4.8%
Next earnings date
Next earnings date
29/04/2027 (in 194 days)
Volatility around earnings
~4% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Formycon
Formycon stock metrics
P/E
-14.03
P/B
0.91
EV/EBITDA
30.27
RETURN ON EQUITY
-3.8%
NET MARGIN
-56.8%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
45.3%
FLOAT SHARES
8,002,643
AVG. DAILY VOLUME (30D)
4,229
Comparable stocks
Frequently asked questions about Formycon stock
What does Formycon do?
Formycon AG is a company in the Healthcare sector, Biotechnology industry, headquartered in Germany.
The CEO is Stefan Glombitza, the company employs around 196 people.
The IPO was on 04/01/2011; the stock trades on XETRA under the ticker FYB.DE.
When does Formycon report next?
The next earnings date is 29/04/2027.
Around past earnings, price swings were roughly -4% stronger than usual.
Does Formycon pay a dividend?
No, Formycon currently does not pay a dividend.
Which stocks are comparable to Formycon?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Formycon stock analyzed?
Clicking "Analyze stock" lets five strategies assess Formycon against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.